The clinical trial program
A drug is only as trustworthy as the trials behind it, so this unit walks the survodutide program in order: the Phase…
How survodutide was tested, step by step
A drug is only as trustworthy as the trials behind it, so this unit walks the survodutide program in order: the Phase 1 studies that first showed both receptors engaged, the Phase 2 trial in diabetes and a Phase 1 study in cirrhosis, and the sprawling SYNCHRONIZE Phase 3 family, now partly reported. Understanding how each trial is built, and what an estimand actually means, is what lets you read a headline result critically.
The theme is that survodutide has three positive Phase 3 readouts, two in obesity and one in liver fat, and, as of the September 2026 registry check, a great deal of work with no results posted, so the evidence is strong but incomplete.